Sutro Biopharma's total assets for Q2 2025 were $262.36M, a decrease of -18.38% from the previous quarter. STRO total liabilities were $294.47M for the fiscal quarter, a -15.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.